Skip to content

Author

Long Jiang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Preclinical evaluation of AL-001, a gene therapy for wet age-related macular degeneration

Suprachoroidal administration of AL-001 is well tolerated and provides durable, targeted aflibercept expression with pronounced antiangiogenic efficacy, and these results support AL-001 as a promising, long-acting therapeutic candidate for wAMD.

Xuan Liu, Hai-Yan Liu, Lei Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.